Literature DB >> 7974199

Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.

J N Nobrega1, P Seeman.   

Abstract

Previous work with membrane preparations had demonstrated that the agonist (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) labels the high-affinity state of dopamine D2 receptors with 67-fold selectivity over D1 sites. In this study, quantitative autoradiography was used to examine the binding of [3H](+)PHNO to rat brain sections. Highest binding densities were found in caudate-putamen, accumbens, and olfactory tubercles, as expected, and also in specific layers of the olfactory bulb. In addition, a second group of brain regions, including lateral septum, entorhinal cortex, molecular layer of hippocampus, and several brainstem structures showed low but consistent levels of binding. In all brain regions [3H](+)PHNO binding (2 nM) was completely displaced by 10 microM sulpiride (> 99%). Addition of 150 microM guanilylimidodiphosphate, which normally converts D2 receptors from high to low affinity states, abolished [3H](+)PHNO binding in all brain regions (> 99%), except for the islands of Callejas. This is likely to reflect binding to D3 sites in this area. Omission of preincubation in binding assays decreased [3H](+)PHNO binding in a regionally dependent manner, with strongest effects (22%) seen in high-density areas. These preincubation results confirm that (+)PHNO may have limitations for in vivo imaging studies. On the other hand, [3H](+)PHNO's negligible levels of non-specific binding compared to other agonists and overall selectivity would make it an excellent tool for in vitro autoradiographic monitoring of the high affinity state of D2 receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7974199     DOI: 10.1002/syn.890170305

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  9 in total

1.  D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction.

Authors:  Esmaeil Mansouri; José N Nobrega; Matthew N Hill; Rachel F Tyndale; Francis S Lee; Christian S Hendershot; Laura M Best; Patricia Di Ciano; Georgia Balsevich; Mathew E Sloan; Stephen J Kish; Junchao Tong; Bernard Le Foll; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2019-11-27       Impact factor: 7.853

2.  Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

Authors:  Ivonne Suridjan; Pablo Rusjan; Jean Addington; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

3.  PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.

Authors:  Jogeshwar Mukherjee; Divya Majji; Jasmeet Kaur; Cristian C Constantinescu; Tanjore K Narayanan; Bingzhi Shi; Mohamed T Nour; Min-Liang Pan
Journal:  Synapse       Date:  2016-11-30       Impact factor: 2.562

4.  The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.

Authors:  Patrick N McCormick; Shitij Kapur; Ariel Graff-Guerrero; Roger Raymond; José N Nobrega; Alan A Wilson
Journal:  Neuropsychopharmacology       Date:  2010-04-21       Impact factor: 7.853

5.  Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.

Authors:  Alice Egerton; Ella Hirani; Rabia Ahmad; David R Turton; Diana Brickute; Lula Rosso; Oliver D Howes; Sajinder K Luthra; Paul M Grasby
Journal:  Synapse       Date:  2010-04       Impact factor: 2.562

6.  Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Authors:  Ariel Graff-Guerrero; Matthaeus Willeit; Nathalie Ginovart; David Mamo; Romina Mizrahi; Pablo Rusjan; Irina Vitcu; Philip Seeman; Alan A Wilson; Shitij Kapur
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

7.  Effects of exposure to chronic uncertainty and a sensitizing regimen of amphetamine injections on locomotion, decision-making, and dopamine receptors in rats.

Authors:  Victoria Fugariu; Martin H Zack; José N Nobrega; Paul J Fletcher; Fiona D Zeeb
Journal:  Neuropsychopharmacology       Date:  2020-01-06       Impact factor: 7.853

8.  Involvement of dopamine D2 receptor in the diurnal changes of tuberoinfundibular dopaminergic neuron activity and prolactin secretion in female rats.

Authors:  Shu-Ling Liang; Sheng-Chieh Hsu; Jenn-Tser Pan
Journal:  J Biomed Sci       Date:  2014-05-03       Impact factor: 8.410

9.  Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain.

Authors:  Arkadiusz Komorowski; Ana Weidenauer; Matej Murgaš; Ulrich Sauerzopf; Wolfgang Wadsak; Markus Mitterhauser; Martin Bauer; Marcus Hacker; Nicole Praschak-Rieder; Siegfried Kasper; Rupert Lanzenberger; Matthäus Willeit
Journal:  Neuroimage       Date:  2020-08-17       Impact factor: 6.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.